A second case of secondary acute myeloblastic leukemia associated with the MLL-KIAA0284 fusion gene.
De Braekeleer
Etienne
E
Ianotto
Jean-Christophe
JC
Douet-Guilbert
Nathalie
N
Meyer
Claus
C
Morel
Frédéric
F
Le Bris
Marie-Josée
MJ
Marschalek
Rolf
R
Berthou
Christian
C
Férec
Claude
C
De Braekeleer
Marc
M
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D001483:Base Sequence; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects; D019457:Chromosome Breakage; D002880:Chromosomes, Human, Pair 11 / Q000235:genetics* / Q000648:ultrastructure; D002883:Chromosomes, Human, Pair 14 / Q000235:genetics* / Q000648:ultrastructure; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D003841:Deoxycytidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D017809:Fatal Outcome; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data; D009381:Neoplasms, Radiation-Induced / Q000235:genetics; D016609:Neoplasms, Second Primary / Q000235:genetics*; D009392:Nephrectomy; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D018714:Radiotherapy, Adjuvant / Q000009:adverse effects; D014571:Urologic Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery; D000093542:Gemcitabine
C542656:MLL-KIAA0284 fusion protein, human; D015514:Oncogene Proteins, Fusion; D003561:Cytarabine; D003841:Deoxycytidine; D002945:Cisplatin; D003630:Daunorubicin; D000093542:Gemcitabine